Goodwin Procter advised TELA Bio, while Latham & Watkins advised the underwriters on the offering. TELA Bio, Inc. has announced the pricing of its previously announced underwritten...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Immuneering in the offering, while Sidley Austin represented the underwriters involved. Immuneering Corporation (Nasdaq: IMRX) announced the pricing of its underwritten offering...
You must be a Standard 1 Year member to access this content.
NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters and placements agents in the transaction. Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering. Herbalife Nutrition Ltd. (NYSE: HLF) has announced the pricing of its offering of US$250 million aggregate...
You must be a Standard 1 Year member to access this content.
Goodwin Procter represented Intellia Therapeutics, while Latham & Watkins LLP represented the underwriter in the offering. Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented VillageMD in the transaction, Cleary Gottlieb and McDermott Will & Emery represented Summit Health-CityMD, while Wachtell, Lipton, Rosen & Katz served as legal...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of...
You must be a Standard 1 Year member to access this content.
Cooley represented Immunovant, while Latham & Watkins represented the underwriters in the offering. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for...
You must be a Standard 1 Year member to access this content.
